Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 164

Results For "Men"

10140 News Found

WHO declares Ebola outbreak, Indians advised against travel to affected regions
Public Health | May 25, 2026

WHO declares Ebola outbreak, Indians advised against travel to affected regions

No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease


Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma
News | May 25, 2026

Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma

The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment


AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%
Clinical Trials | May 25, 2026

AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%

The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial


Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026
R&D | May 25, 2026

Sumitomo Pharma unveils new COURAGE & OPTYX data at AUA 2026

Highlights strong Vibegron results in older men & real-world prostate cancer insights


Datroway wins US nod in aggressive breast cancer subtype
Drug Approval | May 25, 2026

Datroway wins US nod in aggressive breast cancer subtype

Clearance marks major shift beyond chemotherapy


Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors
News | May 25, 2026

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks


SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth
News | May 25, 2026

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

Revenue from operations climbed 13% to Rs. 886.87 crore


Zota Health Care posts 83.86% revenue surge in FY26
Healthcare | May 25, 2026

Zota Health Care posts 83.86% revenue surge in FY26

Expands Davaindia network to 2,579 stores


EU regulator backs Allergan Aesthetics’ Boey in key step toward approval
Drug Approval | May 25, 2026

EU regulator backs Allergan Aesthetics’ Boey in key step toward approval

The decision marks a key step in the centralized EU review process


Lilly brings heavy oncology firepower to ASCO with plenary data across cancers
R&D | May 25, 2026

Lilly brings heavy oncology firepower to ASCO with plenary data across cancers

The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy